The global ecology and epidemiology of West Nile virus

C Chancey, A Grinev, E Volkova… - BioMed research …, 2015 - Wiley Online Library
Since its initial isolation in Uganda in 1937 through the present, West Nile virus (WNV) has
become an important cause of human and animal disease worldwide. WNV, an enveloped …

Dengue virus and the host innate immune response

N Uno, TM Ross - Emerging microbes & infections, 2018 - Taylor & Francis
Dengue virus (DENV) is a mosquito-borne Flavivirus that is endemic in many tropical and
sub-tropical countries where the transmission vectors Aedes spp. mosquitoes resides. There …

Zika virus structure, maturation, and receptors

D Sirohi, RJ Kuhn - The Journal of infectious diseases, 2017 - academic.oup.com
The emergence of Zika virus (ZIKV) as a major public health threat has focused research on
understanding virus biology and develo** a suite of strategies for disease intervention …

New insights into the immunopathology and control of dengue virus infection

G Screaton, J Mongkolsapaya, S Yacoub… - Nature Reviews …, 2015 - nature.com
Dengue virus poses a major threat to global public health: two-thirds of the world's
population is now at risk from infection by this mosquito-borne virus. Dengue virus causes a …

The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry

L Meertens, X Carnec, MP Lecoin, R Ramdasi… - Cell host & …, 2012 - cell.com
Dengue viruses (DVs) are responsible for the most medically relevant arboviral diseases.
However, the molecular interactions mediating DV entry are poorly understood. We …

Receptors and routes of dengue virus entry into the host cells

C Cruz-Oliveira, JM Freire… - FEMS microbiology …, 2015 - academic.oup.com
Dengue is the most prevalent arthropod-borne viral disease, caused by dengue virus, a
member of the Flaviviridae family. Its worldwide incidence is now a major health problem …

Flavivirus entry receptors: an update

M Perera-Lecoin, L Meertens, X Carnec, A Amara - Viruses, 2013 - mdpi.com
Flaviviruses enter host cells by endocytosis initiated when the virus particles interact with
cell surface receptors. The current model suggests that flaviviruses use at least two different …

Antibody-dependent enhancement: a challenge for develo** a safe dengue vaccine

R Shukla, V Ramasamy, RK Shanmugam… - Frontiers in cellular …, 2020 - frontiersin.org
In 2019, the United States Food and Drug Administration accorded restricted approval to
Sanofi Pasteur's Dengvaxia, a live attenuated vaccine (LAV) for dengue fever, a mosquito …

Insights into dengue immunity from vaccine trials

EE Ooi, S Kalimuddin - Science translational medicine, 2023 - science.org
The quest for an effective dengue vaccine has culminated in two approved vaccines and
another that has completed phase 3 clinical trials. However, shortcomings exist in each …

The human antibody response to dengue virus infection

WMPB Wahala, AM De Silva - Viruses, 2011 - mdpi.com
Dengue viruses (DENV) are the causative agents of dengue fever (DF) and dengue
hemorrhagic fever (DHF). Here we review the current state of knowledge about the human …